GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novogene Co Ltd (SHSE:688315) » Definitions » Debt-to-Equity

Novogene Co (SHSE:688315) Debt-to-Equity : 0.02 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Novogene Co Debt-to-Equity?

Novogene Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥30 Mil. Novogene Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥20 Mil. Novogene Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥2,532 Mil. Novogene Co's debt to equity for the quarter that ended in Mar. 2025 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Novogene Co's Debt-to-Equity or its related term are showing as below:

SHSE:688315' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02   Med: 0.03   Max: 0.26
Current: 0.02

During the past 10 years, the highest Debt-to-Equity Ratio of Novogene Co was 0.26. The lowest was 0.02. And the median was 0.03.

SHSE:688315's Debt-to-Equity is ranked better than
88.87% of 1024 companies
in the Biotechnology industry
Industry Median: 0.14 vs SHSE:688315: 0.02

Novogene Co Debt-to-Equity Historical Data

The historical data trend for Novogene Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novogene Co Debt-to-Equity Chart

Novogene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.03 0.03 0.02 0.02

Novogene Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.02 0.02

Competitive Comparison of Novogene Co's Debt-to-Equity

For the Biotechnology subindustry, Novogene Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novogene Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novogene Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Novogene Co's Debt-to-Equity falls into.


;
;

Novogene Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Novogene Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Novogene Co's Debt to Equity Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novogene Co  (SHSE:688315) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Novogene Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Novogene Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Novogene Co Business Description

Traded in Other Exchanges
N/A
Address
No. 29, Shengshengyuan Road, Room B258, Innovation Building, Huilongguan Town, Changping District, Beijing, CHN, 100015
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.

Novogene Co Headlines

No Headlines